The National Health Insurance Administration officially issued a letter, a large number of varieties will not have health insurance.

Medical Network August 3, the State Administration of Health Insurance officially issued a letter, a large number of varieties will be without medical insurance 1, a large number of varieties will be without medical insurance late july 31st night, the State Medical Insurance Administration officially issued the "Temporary Measures for the Administration of Basic Medical Insurance Drug Administration" (hereinafter referred to as the "Measures").
the Measures for the formulation and adjustment of the national medical insurance directory to make clear, clearly establish a perfect dynamic adjustment mechanism, in principle, the national health insurance directory adjusted once a year.
which varieties will be transferred out or no longer included in the health insurance list, which is worthy of the attention of pharmaceutical companies.
In accordance with Article 8 of the Measures, the eight major categories of drugs, such as medicines and health-care drugs, which mainly play a tonic role, are not included in the medical insurance catalogue: Article 9 of the Measures stipulates that drugs with the following circumstances shall be transferred directly out of the medical insurance catalogue: "Article 10 of the Measures stipulates that if they meet the following conditions, the medical insurance catalogue may be transferred: In addition, Article 36 of the Measures clearly stipulates that, in principle, the Drug Catalog will no longer be added to the OTC drug.
from the requirements of the health insurance catalog, with the dynamic adjustment of the health insurance catalog, there will be a large number of varieties will be transferred out of the health insurance directory.
at the same time, some out-of-the-directory want to squeeze into the health care catalog of varieties, will also be from the health care catalog.
2, the variety of health insurance transferred, and the opportunity for the adjustment of the health insurance catalog to affect the entire pharmaceutical market.
whether it is the dynamic adjustment of the national health insurance directory, or the local health insurance directory for three years of gradual clean-up, many of the original in the health insurance channels to the varieties will face a great impact.
in addition, the national collection has also had a certain impact on the pharmaceutical industry, those hospital market affected, or can not enter the hospital market pharmaceutical companies, need more attention to out-of-hospital channels.
a pharmaceutical company told Seberlan that the company has developed a strategy in advance for local supplements.
is to try to get into the national general health insurance directory or the national health care negotiations before clearing out the local health insurance directory, and the second is to go through the self-funded channels and try to open up new reimbursement channels.
the company is already adjusting its market strategy to prepare for the market impact of the health-care adjustment and national harvest.
So, for the failure to enter the medical insurance reimbursement channels or failed to enter the hospital market varieties, how can pharmaceutical companies take up the out-of-hospital market? How do I reach patients who have a need for their products? As we all know, the future pharmaceutical system can not be separated from the Internet, only "medical, medicine, insurance" three-way interaction, in order to really open up the business model, change the existing pharmaceutical sales of the entire form, to achieve mutual benefit and win-win situation.
drug companies and commercial insurance, health management, pharmaceutical e-commerce and Internet hospitals, such as cooperation, are very worthy of exploration.
to miao health as an example, for the combination of pharmaceutical companies and commercial insurance landing there are two service solutions: the first is relying on the health management ability of miao health management, data as a grasp, integration of pharmaceutical, insurance resources, to create a "drug and service and insurance" integrated product solutions.
assist pharmaceutical companies to customize personalized insurance products with insurance companies, then closely connect the two through health management services to create a patient-centered overall service solution, and the second is around the in-hospital prescription flow needs, based on the Group's health management, Internet hospitals, pharmaceutical and e-commerce platform and insurance resources and capabilities, to provide pharmaceutical companies with technology, services, qualifications and resources of the full range of capacity output, to create a comprehensive integrated service platform for doctors, patients, services and insurance.
No matter what form pharmaceutical companies and insurance through the combination, are expected to open up a new marketing channel to promote product sales, and ultimately create more value for consumers.
can expect that in the future, the commercial insurance and pharmaceutical industry will be more closely linked, the two sides will collide with more innovative service models, together to open up more incremental market.
3, which varieties, more market opportunities? On November 12, 2019, the Circ announced the newly revised Measures for health insurance management on its official website.
the new rules to "encourage new products to adapt to new needs" and "support health management" to make "sickness insurance" possible.
the World Health Organization data show that 15% of the population in China is in a healthy state, 15% of the diseased population, 70% in the sub-health state.
so it's understandable that the previous commercial health insurance market was focused only on the 15 percent of the healthy population, with the remaining 85 percent having greater insurance needs and market potential.
according to arterial network finishing, before there have been a number of insurance companies to take the lead in exploring disease insurance, the disease areas involved include diabetes, osteoporosis, hepatitis C, chronic kidney disease, lung cancer, breast cancer and so on.
(Photo Source: Artery Network) Health Management Blue Book: China's Health Management and Health Industry Development Report (2018) data show that the number of people with chronic diseases in China is about 300 million people, the potential demand for drugs is also immeasurable.
said that under the disease insurance, will be able to improve the compliance of patients, make the use of drugs more scientific and reasonable, while better treatment results.
for example, Taikang Online's hospitalization benefit insurance for specific respiratory diseases makes it clear that patients who "must continue to take the double antiplatelet medication recommended in the guidelines for 12 months" can only be covered by the program. which drugs
have a better chance of being covered by sickness insurance? Miao Health CEO Kong Fei told Seiber Lan, generally speaking, special drugs, chronic disease drugs and commercial insurance will be closer, at present, the market has appeared a number of special drug-related products and services, but the insurance of chronic drugs is not much.
for patients who have a drug need, but are not covered by health insurance, can be considered for commercial insurance.
but he also said that specific to a certain disease, must have the support of basic data, in order to effectively control the risk, for pharmaceutical companies, insurance to produce value.
4, trillion market, the future may be scheduled, the General Office of the State Council issued "on the issuance and deepening of the reform of the medical and health system in the second half of 2020 key tasks notice."
mentions the accelerated development of commercial health insurance.
encourage commercial insurance institutions to provide comprehensive health insurance products and services that include multiple protections for medical care, disease, rehabilitation, care, childbirth, etc.
actively introduce social forces to participate in medical security services.
as an important part of the insurance component, commercial health insurance is becoming more and more important.
in recent years, commercial health insurance has been frequently written into important national documents.
with the introduction of a series of policies to support commercial health insurance, the future, commercial health insurance will take advantage of the policy of the east wind, rapid and healthy development.
Seiber Blue combed the data disclosed by the China Banking Regulatory Commission and found that disease and medical insurance accounted for the vast majority of the original premium income of 706.6 billion yuan in 2019, accounting for 99% of the total.
According to the statistics of the Bank circoning policy, in the first quarter of 2020, China's health insurance business achieved original premium income of 264.1 billion yuan, up 21.6% year-on-year.
forecast sized, the health insurance market is expected to reach trillions of dollars by 2020.
(data source: China Banking Regulatory Commission) when it comes to health insurance, it is inseparable from the topic of the pharmaceutical industry. Kong Fei, CEO of
-Miao Health, told Seibrand that drug insurance, as an important part of health insurance, is also growing rapidly with the market, the share of the market will be larger and larger, the development trend is worthy of the attention of pharmaceutical companies.
he believes that allowing coverage of disease sisicans will become an industry trend, and that health management services that include related drugs in the disease insurance species are more critical.
the three-way cooperation between pharmaceutical companies, insurance and health management agencies, from health management to medical treatment, drug use to insurance compensation, to create a "drug and service and insurance" complete health plan, the formation of the industrial chain service closed loop, in order to achieve the goal of reducing cost-effective, share trillion market cake.
.